Pan-Cancer Analysis Identifies <i>MNX1</i> and Associated Antisense Transcripts as Biomarkers for Cancer
The identification of diagnostic and prognostic biomarkers is a major objective in improving clinical outcomes in cancer, which has been facilitated by the availability of high-throughput gene expression data. A growing interest in non-coding genomic regions has identified dysregulation of long non-...
Main Authors: | Denise Ragusa, Sabrina Tosi, Cristina Sisu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/11/22/3577 |
Similar Items
-
MNX1-AS1 is a functional oncogene that induces EMT and activates the AKT/mTOR pathway and MNX1 in breast cancer
by: Cheng Y, et al.
Published: (2019-01-01) -
MNX1 Promotes Malignant Progression of Cervical Cancer via Repressing the Transcription of p21cip1
by: Biqing Zhu, et al.
Published: (2020-08-01) -
Zebrafish Mnx proteins specify one motoneuron subtype and suppress acquisition of interneuron characteristics
by: Seredick Steve D, et al.
Published: (2012-11-01) -
Upregulated expression of MNX1-AS1 long noncoding RNA predicts poor prognosis in gastric cancer
by: Wei Zhang, et al.
Published: (2019-05-01) -
MNX1 mutations causing neonatal diabetes: Review of the literature and report of a case with extra‐pancreatic congenital defects presenting in severe diabetic ketoacidosis
by: Hanan Hassan Aly, et al.
Published: (2023-04-01)